Early developments toward HbA1c determination in whole blood by high-speed sample preparation and LC–MS/MS analysis

We report a method to determine HbA<sub>1c</sub> (glycated hemoglobin) where whole blood samples are prepared by fast hemolysis (dilution with deionized water and vortex mixing), digestion with 0.6 mg/mL endoproteinase Glu C (Glu C) in 30 mM ammonium acetate buffer (pH 4.3) at 37 °C for 45 min, and termination of the digestion by diluting with 0.1% formic acid in water, and then analysis by a gradient liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with a run time of 36 s. The method is linear between 0 and 200 HbA<sub>1c</sub>/mol Hb (IFCC) with a correlation coefficient of 0.999, providing an inter-day reproducibility between 1.3 and 2.3% CV, and comparable with results from analysis of the same samples on the Roche Cobas® c 513 clinical analyzer with a correlation coefficient of 0.998. In two alternative detection workflows that were not characterized in detail, the same digested samples were purified by a magnetic bead-based solid-phase extraction (SPE) method requiring about 10 min and then analyzed using either an isocratic LC-MS/MS method or a flow injection analysis (FIA)-MS/MS method with run times of 12 s and 18 s, respectively. Our work demonstrates the feasibility of LC-MS-based methods for HbA<sub>1c</sub> determination that minimize the time required for sample preparation and measurement while preserving analytical performance and are thereby more suitable for routine clinical settings compared to traditional methods which require up to 25 h and 23 min, respectively, to prepare and measure samples.

Authors

Institutions

Publication Details

Journal
Analytical and Bioanalytical Chemistry
Published
2024-10-26
DOI
https://doi.org/10.1007/s00216-024-05601-5
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early developments toward HbA1c determination in whole blood by high-speed sample preparation and LC–MS/MS analysis

Thomas Dülffer, Martin E. Silvestre, Lars Hillringhaus, Andreas Huber et al.
Analytical and Bioanalytical Chemistry
Diabetes Management and Research
article

Early developments toward HbA1c determination in whole blood by high-speed sample preparation and LC–MS/MS analysis

Thomas Dülffer, Martin E. Silvestre, Lars Hillringhaus, Andreas Huber, Andrea Geistanger, Andreas Leinenbach, Susanne Adam, Indranil Mitra, Sven Vopel, Holger Busskamp
article en

Abstract

We report a method to determine HbA<sub>1c</sub> (glycated hemoglobin) where whole blood samples are prepared by fast hemolysis (dilution with deionized water and vortex mixing), digestion with 0.6 mg/mL endoproteinase Glu C (Glu C) in 30 mM ammonium acetate buffer (pH 4.3) at 37 °C for 45 min, and termination of the digestion by diluting with 0.1% formic acid in water, and then analysis by a gradient liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with a run time of 36 s. The method is linear between 0 and 200 HbA<sub>1c</sub>/mol Hb (IFCC) with a correlation coefficient of 0.999, providing an inter-day reproducibility between 1.3 and 2.3% CV, and comparable with results from analysis of the same samples on the Roche Cobas® c 513 clinical analyzer with a correlation coefficient of 0.998. In two alternative detection workflows that were not characterized in detail, the same digested samples were purified by a magnetic bead-based solid-phase extraction (SPE) method requiring about 10 min and then analyzed using either an isocratic LC-MS/MS method or a flow injection analysis (FIA)-MS/MS method with run times of 12 s and 18 s, respectively. Our work demonstrates the feasibility of LC-MS-based methods for HbA<sub>1c</sub> determination that minimize the time required for sample preparation and measurement while preserving analytical performance and are thereby more suitable for routine clinical settings compared to traditional methods which require up to 25 h and 23 min, respectively, to prepare and measure samples.

Analytical and Bioanalytical ChemistryVol. 416(29)
Roche (United States) (US), Roche Pharma AG (Germany) (DE)
Openalex Percentile: Top 70%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.